Wesleyan Assurance Society Organon & Co. Transaction History

Wesleyan Assurance Society

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$16.59 - $23.77 $94,563 - $135,489	-5,700 Reduced 81.43%	1,300 $23,000
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $83,143 - $107,677	-2,900 Reduced 29.29%	7,000 $213,000
Q2 2021 Jul 30, 2021	BUY	$28.45 - $38.0 $281,655 - $376,200	9,900 New	9,900 $299,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Wesleyan Assurance Society, based on Form 13F filings with the SEC.

Stay updated on Wesleyan Assurance Society with notifications on news.